Trial Condition(s):

Prostate Cancer

Patient characteristics, treatment patterns, and resource usage among prostate cancer patients with bone metastasis in China

Bayer Identifier:

18324

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The primary objectives of this study were to estimate the prevalence of both all prostate cancer and of prostate cancer with bone metastasis among urban employees in Beijing and Jinan from 2011 to 2014, and to described characteristics of those with bone metastasis. The secondary objective was to describe the common treatment pattern, resource use and treatment costs of prostate cancer patients with bone metastasis in Beijing and Jinan from 2011 to 2014.

Inclusion Criteria
- prostate cancer-related words were included in the diagnosis
- the ICD-10 code was C61, C79.5 or M84.4
- the use of bisphosphonates or anti-tumor drugs, including radiation therapy drugs, chemotherapy drugs and endocrine drugs, was included in the medication administration record
- surgery or radiation therapy was included in the medical record
Exclusion Criteria
- differential diagnosis, such as Osteoporosis, fracture need to be excluded

Trial Summary

Enrollment Goal
2134
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design